Selective Tumor Hypoxia Targeting Using M75 Antibody Conjugated Photothermally Active MoO
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
22
03
2023
revised:
24
07
2023
accepted:
02
11
2023
medline:
4
12
2023
pubmed:
4
12
2023
entrez:
4
12
2023
Statut:
epublish
Résumé
Photothermal therapy (PTT) mediated at the nanoscale has a unique advantage over currently used cancer treatments, by being spatially highly specific and minimally invasive. Although PTT combats traditional tumor treatment approaches, its clinical implementation has not yet been successful. The reasons for its disadvantage include an insufficient treatment efficiency or low tumor accumulation. Here, we present a promising new PTT platform combining a recently emerged two-dimensional (2D) inorganic nanomaterial, MoO
Identifiants
pubmed: 38046334
doi: 10.1021/acsomega.3c01934
pmc: PMC10688043
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44497-44513Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Int J Oncol. 2004 Apr;24(4):995-1004
pubmed: 15010840
Nanomedicine. 2020 Nov;30:102280
pubmed: 32771421
Drug Deliv. 2017 Dec;24(sup1):1-15
pubmed: 29069934
Int J Pharm. 2021 Sep 5;606:120846
pubmed: 34216769
Adv Mater. 2017 Oct;29(40):
pubmed: 28815807
Chem Asian J. 2017 Dec 5;12(23):2980-2984
pubmed: 28885770
Adv Drug Deliv Rev. 2013 Jan;65(1):71-9
pubmed: 23088862
Pharmaceuticals (Basel). 2022 May 02;15(5):
pubmed: 35631396
Adv Mater. 2014 Jun 18;26(23):3931-7
pubmed: 24677332
Biomaterials. 2016 Jan;76:11-24
pubmed: 26517561
Theranostics. 2019 May 18;9(11):3308-3340
pubmed: 31244956
Nat Rev Drug Discov. 2021 Feb;20(2):101-124
pubmed: 33277608
Sensors (Basel). 2010;10(3):1871-89
pubmed: 21151763
Front Bioeng Biotechnol. 2020 Oct 29;8:544311
pubmed: 33195114
Nanoscale. 2017 Jun 22;9(24):8298-8304
pubmed: 28585945
Front Mol Biosci. 2020 Aug 20;7:193
pubmed: 32974385
Int J Cancer. 2003 Jul 20;105(6):873-81
pubmed: 12767076
Nanoscale. 2018 Jan 18;10(3):1517-1531
pubmed: 29303196
Langmuir. 2005 Jan 4;21(1):225-8
pubmed: 15620307
Nano Lett. 2017 Jun 14;17(6):3854-3861
pubmed: 28537732
Analyst. 2018 Jul 23;143(15):3686-3692
pubmed: 29978167
Int J Mol Sci. 2019 Jun 04;20(11):
pubmed: 31167468
J Am Chem Soc. 2020 Jan 22;142(3):1636-1644
pubmed: 31880441
Cancer Res. 2011 Dec 15;71(24):7558-67
pubmed: 22037869
Nanoscale. 2022 Oct 13;14(39):14471-14481
pubmed: 36156057
Oncogene. 1994 Oct;9(10):2877-88
pubmed: 8084592
Eur J Pharmacol. 2011 Apr 25;657(1-3):173-83
pubmed: 21315712
Photodermatol Photoimmunol Photomed. 2012 Jun;28(3):147-52
pubmed: 22548397
Biochem Biophys Res Commun. 2004 Dec 17;325(3):1005-12
pubmed: 15541389
Biomater Sci. 2020 Mar 31;8(7):1973-1980
pubmed: 32065173
ACS Appl Mater Interfaces. 2014 Mar 26;6(6):3915-22
pubmed: 24564332
J Mater Chem B. 2019 Mar 28;7(12):2032-2042
pubmed: 32254807
J Nanobiotechnology. 2021 Dec 19;19(1):428
pubmed: 34923976
Methods Cell Biol. 2014;123:77-94
pubmed: 24974023
Langmuir. 2012 May 29;28(21):8046-51
pubmed: 22554237
Cancer Metastasis Rev. 2021 Dec;40(4):1035-1053
pubmed: 35080763
Semin Cancer Biol. 2015 Apr;31:52-64
pubmed: 25117006
Nat Commun. 2018 Dec 21;9(1):5421
pubmed: 30575745
Adv Drug Deliv Rev. 2015 Jul 15;89:71-90
pubmed: 25728764
Analyst. 2016 Jun 21;141(12):3590-600
pubmed: 27072718
Angew Chem Int Ed Engl. 2014 Jun 16;53(25):6322-56
pubmed: 24849332
Phys Chem Chem Phys. 2011 Apr 28;13(16):7330-9
pubmed: 21390378
J Hematol Oncol. 2022 Sep 12;15(1):132
pubmed: 36096856
Biomed Mater. 2021 Aug 04;16(5):
pubmed: 34280914
Langmuir. 2006 May 9;22(10):4649-53
pubmed: 16649777
Adv Colloid Interface Sci. 2021 Oct;296:102509
pubmed: 34455211
Phys Chem Chem Phys. 2019 Jun 21;21(23):12396-12405
pubmed: 31140503
Metabolites. 2018 Feb 10;8(1):
pubmed: 29439394
Chemistry. 2012 Nov 26;18(48):15283-7
pubmed: 23129418
Virology. 1992 Apr;187(2):620-6
pubmed: 1312272
Sci Rep. 2017 Aug 21;7(1):8945
pubmed: 28827720
J Ovarian Res. 2012 Jan 27;5(1):6
pubmed: 22284433
Part Fibre Toxicol. 2017 Jun 24;14(1):22
pubmed: 28646905
Analyst. 2012 Mar 7;137(5):1111-9
pubmed: 22273712
J Lipid Res. 2017 May;58(5):876-883
pubmed: 28143895
Chem Commun (Camb). 2016 Feb 18;52(14):2893-6
pubmed: 26732505
Langmuir. 2019 Jul 23;35(29):9554-9563
pubmed: 31290675
Genomics. 1996 May 1;33(3):480-7
pubmed: 8661007
Front Chem. 2018 Aug 28;6:363
pubmed: 30211151
Sci Rep. 2016 Sep 26;6:33562
pubmed: 27666523
PLoS One. 2014 Jul 11;9(7):e101997
pubmed: 25013915
BJU Int. 2008 Jun;101 Suppl 4:8-15
pubmed: 18430116
Nanotechnology. 2020 Nov 03;32(4):045708
pubmed: 33140739
Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2122-6
pubmed: 26710169
Langmuir. 2010 Jan 5;26(1):156-64
pubmed: 20000361
Nanoscale. 2017 Feb 2;9(5):2020-2029
pubmed: 28106206